dCas9-NS3-NLS/VPR
(Plasmid
#112244)
-
PurposeEncodes the drug-preservable Cas9-NS3-NLS/VPR, which can be used to activate gene expression when combined with an NS3 inhibitor and appropriately designed sgRNA.
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 112244 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepcDNA3
- Backbone size w/o insert (bp) 5500
- Total vector size (bp) 12204
-
Modifications to backboneHygromycin resistance
-
Vector typeMammalian Expression
-
Selectable markersHygromycin
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert namedCas9-NS3-NLS/VPR
-
SpeciesS. pyogenes
-
Insert Size (bp)6700
-
MutationNS3 mutant T54A
- Promoter CMV
-
Tags
/ Fusion Proteins
- HA (C term on NS3)
- AU1 (N term on NS3)
Cloning Information
- Cloning method Gibson Cloning
- 5′ sequencing primer CMV-Forward
- 3′ sequencing primer BGH-Reverse (Common Sequencing Primers)
Resource Information
-
Supplemental Documents
-
A portion of this plasmid was derived from a plasmid made bydCas9-VPR was adapted from Chavez et al., 2015 (Addgene plasmid #63798) and NS3 was adapted from the Roger Tsien lab.
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
dCas9-NS3-NLS/VPR was a gift from John Ngo (Addgene plasmid # 112244 ; http://n2t.net/addgene:112244 ; RRID:Addgene_112244) -
For your References section:
Chemogenetic control of gene expression and cell signaling with antiviral drugs. Tague EP, Dotson HL, Tunney SN, Sloas DC, Ngo JT. Nat Methods. 2018 Jul;15(7):519-522. doi: 10.1038/s41592-018-0042-y. Epub 2018 Jul 2. 10.1038/s41592-018-0042-y PubMed 29967495